The Obesity Answer That's Already Written In Your Body
- Arvind Pawar
- May 9
- 3 min read
Arvind Pawar
Co-founder of Hyperlink Health
Why "Eat Less, Move More" Keeps Failing You
Three cousins.
Same dal-chawal dinner table growing up.
Same Sunday parathas,
same evening chai.
At 32, one's pre-diabetic.
One runs half marathons.
One has been on "the same weight loss plan" for a decade and can't understand why nothing moves.
Same food.
Radically different bodies.
Nobody talks about this.
Here's what nobody's saying out loud: the plan you're on might not be broken in the first place, it might just be someone else's plan, built for someone else's biology. and you've been blaming your discipline for a genetic mismatch.
Mainstream Indian weight-loss content almost exclusively defaults to willpower framing.
The "wrong plan for your body, not lack of discipline" angle, anchored in the relatable joint-family food environment, is rarely the entry point.
The global obesity problem isn't just a calorie problem. It's a personalization problem.
Standard advice like cutting carbs, walking daily, and skipping sugar works beautifully for some people and does almost nothing for others.
That isn't failure.
That's biology doing exactly what it was designed to do.
GLP1 Drugs: The Injection Everyone's Whispering About
You've probably heard the name Ozempic.
Maybe Wegovy or Mounjaro.
These are GLP1 receptor agonists, medications that mimic a gut hormone to suppress appetite and slow digestion.
Clinically validated.
Increasingly available in India.
Real results for real people.
GLP1 drugs work.
That's the uncomfortable truth. but "works" is doing a lot of heavy lifting in that sentence, because it works the way renting solves a housing problem.
You stop paying, you're back outside. Most people regain significant weight within a year of stopping.
Pro-GLP1 content oversells outcomes.
Anti-GLP1 content moralizes.
The renting metaphor, especially resonant for an Indian audience, where homeownership carries deep psychological weight, reframes the short-term vs long-term trade-off without passing judgment.
For people dealing with severe metabolic dysfunction or high BMI-related health risks, GLP1 medications can be genuinely life-changing.
They reduce appetite, improve insulin sensitivity, and give the body a window to reset.
The quieter side of the story: they don't address why your body was storing fat in the first place.
The underlying hormonal patterns, the metabolic tendencies, the genetic predispositions, they're still there the moment you stop. Not wrong. Just incomplete.
Your Genes Already Filed the Complaint. Nobody Read It.
Enter the nutrigenomists.
Consumer DNA panels aren't astrology with a lab coat.
Your PPARG gene variant literally determines whether a low-fat or low-carb diet will fight your biology or work with it.
Most people spend 5 years figuring this out by accident, through trial, failure, shame, what a single test could have told them in a week.
Indian audiences associate genetic testing almost exclusively with ancestry or serious disease screening, rarely with weight management.
Naming a specific gene (PPARG) makes this concrete, not sci-fi, a genuinely low-probability entry angle.
Consumer DNA health panels , similar to what Hyperlink Health offers, with India-specific options emerging, analyze variants that influence how your body processes fats versus carbohydrates, your predisposition to insulin resistance, how efficiently you burn fat during different types of exercise, and whether stress hormones or caffeine metabolism are silently working against you.
This isn't about genetics as destiny. It's genetics as context. Knowing your context means you stop guessing and start targeting.
Instead of "cutting carbs because someone on YouTube lost 12 kilos," you're deciding your specific biology will actually respond to.
No Pain, No Gain: But First, Know Which Pain
The phrase that has been weaponized for a long time: run more, starve more, suffer more.
If you're not exhausted, you're not trying. That framing has sent a lot of people down the wrong road, harder.
People who beat obesity long-term don't always outwork everyone else. They stop fighting their own biology and start fighting the right thing.
The real discipline isn't in the punishment. It's in the patience to understand your body before you start.
"No pain, no gain" is almost universally invoked to motivate more physical effort.
Inverting it to mean diagnostic patience, resisting the quick fix long enough to do the foundational work, is a rare and genuinely uncomfortable reframe.
Whether the path forward is a GLP1 medication, a nutrigenomics-guided lifestyle plan, or eventually a combination of both, the smartest starting point is the same: understand your specific body first.
Everything else is just noise.
Learn more at: https://www.hyperlink.health/ or reach us on arvind.pawar@hyperlink.health
Comments